IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden
· Delayed Price · Currency is SEK 1.600
-0.016 (-0.99%)
At close: Mar 6, 2026
IRLAB Therapeutics AB Revenue
In the year 2025, IRLAB Therapeutics AB had annual revenue of 57.46M SEK, down -39.28%. IRLAB Therapeutics AB had revenue of 14.72M in the quarter ending December 31, 2025, a decrease of -65.61%.
Revenue
57.46M
Revenue Growth
-39.28%
P/S Ratio
2.37
Revenue / Employee
1.85M
Employees
31
Market Cap
135.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.46M | -37.17M | -39.28% |
| Dec 31, 2024 | 94.63M | 88.95M | 1,566.57% |
| Dec 31, 2023 | 5.68M | -55.46M | -90.71% |
| Dec 31, 2022 | 61.14M | -146.65M | -70.58% |
| Dec 31, 2021 | 207.78M | 207.48M | 69,160.67% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NextCell Pharma AB | 9.83M |
| Xbrane Biopharma AB | 152.35M |
| Simris Group AB (PUBL) | 1.62M |
| Magle Chemoswed Holding AB | 300.49M |
| Alligator Bioscience AB | 4.42M |
| Sprint Bioscience AB | 167.17M |
| Biosergen AB | 2.09M |